Photo: in.investing.com
Hims & Hers Q3 Earnings Fall Short, Telehealth Stocks Show Signs of Recovery
Hims & Hers reported mixed Q3 earnings, missing EPS expectations while exceeding revenue forecasts, amid a wider recovery for telehealth stocks.
- Hims & Hers Healths Q3 2025 earnings showed an earnings per share (EPS) of $0.06, missing the expected $0.10, reflecting a 40% negative surprise.
- Despite the EPS miss, Hims & Hers generated revenue of $600 million, surpassing forecasts of $580.37 million, marking a 3.38% positive surprise.
- Following the earnings announcement, Hims & Hers stock rose by 3.45% to $47.03, indicating investor confidence in the recovering telehealth sector.
Why It Matters
The mixed earnings performance of Hims & Hers highlights the ongoing volatility in the telehealth market, as companies navigate post-pandemic challenges while adapting to shifts in consumer behavior, particularly in areas like weight loss and medication such as Semaglutide from Novo Nordisk.